Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given voluntary written consent to participate before any screening takes place (or whose legal representative has done so on their behalf)
- People who are using a highly effective form of contraception, such as implants, injections, combined oral contraceptive pills, certain IUDs, complete abstinence from heterosexual intercourse during the trial period, or whose partner has had a vasectomy
- People who are female
- People aged between 18 and 50 years
- People who have uterine fibroids (myomas) that are considered suitable for surgical removal (myomectomy), excluding certain fibroid types classified as FIGO type 7 or 8 (confirm with trial site)
Who may not be able to join:
- People who have any medical condition that, in the opinion of the investigator, could put them at risk or affect their ability to follow the trial requirements
- People who are receiving or have received other treatments that could affect their safety or interfere with the trial results
- People who are currently participating in another clinical trial involving an investigational medicine or medical device
- People who do not wish to participate in the trial
- People who have a known or suspected cancer or malignancy
- People who have any medical reason that would make laparoscopic or robotic surgery unsafe or unsuitable for them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wouter Froyman, MD, PhD, Universitaire Ziekenhuizen KU Leuven
Phone: +3216348826
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Peri-operative blood loss: Estimated blood loss; Peri-operative blood loss: Hemoglobin drop perioperatively >2g/dL; Peri-operative blood loss: Need for peri-operative blood transfusion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.